The management of Wilms' tumor: A comparison of two regimens
β Scribed by John T. Benjamin; William D. Johnson; Campbell W. McMillan
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- English
- Weight
- 398 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
mately 200/, of all malignant tumors of childhood. It originates from the mesodermal cells formed in the embryo: these cells retain their ability to grow and differentiate.l A clinician confronted by a case of Wilms's tumor must inevitably face the parents' question, "What are my child's chances of
Seventy-two patients with advanced resectable head and cancer received two courses of induction chemotherapy before definitive therapy. Forty-six patients were treated with platinol, Oncovin (vincristine), and bleomycin. Twenty-six received Platinol (cisplatin), Velban (vinblastine), and 5-fluoroura
## BACKGROUND. Approximately 1% of children with unilateral Wilms tumor develop contralateral disease. The authors assessed the demographic and histologic features associated with metachronous bilateral Wilms tumor (BWT). ## METHODS. Characteristics of all children registered on the first four Nat